Lindus Health is a next-gen CRO (Contract Research Organization) that expedites clinical trials, aiming to advance healthcare treatments for various conditions rapidly. They have delivered over 80 trials across the UK, US, and Europe, tackling conditions such as diabetes, asthma, acne, social anxiety, major depressive disorder, hypertension, chronic fatigue syndrome, and insomnia.

Lindus Health

Our mission at Lindus Health is to accelerate clinical trials, so patients can benefit from new treatments sooner. 

We are an anti-CRO running radically faster, more reliable clinical trials for life science pioneers. We do this thanks to a commercial model that aligns incentives (fixed-priced quotes per study, with milestone-based payments), marrying a world-class clinical operations team with our unique software platform, and access to 30 million Electronic Health Records. We handle the end-to-end execution of clinical studies, including design, patient recruitment, clinical data capture, monitoring and project management. 

We have helped over 90 sponsors run entire clinical studies across the US, UK, and Europe up to 3x faster than traditional CROs, with all trials delivered on or ahead of schedule.

Innovate UK

Calm/Storm Ventures

Firstminute Capital

Amino Collective

Seedcamp

Hambro Perks Ltd.

Presight Capital

Creandum

Page One Ventures

Peter Thiel

Introducing our All-In-One CRO solution for the #DTx market!

We’ve run 17 digital therapeutics studies end-to-end (and more to come) within 12 disease indications across the US, UK and Europe. Our offering for DTx sponsors bundles a bespoke DTx implementation of our eClinical software and site/recruitment capabilities, with end-to-end CRO services all backed by leading experience in DTx study execution.

Learn more about this exciting technology and services package here: https://lnkd.in/eSUTzgmJ

#digitaltherapeutics #cro #healthtech

Let’s be real, change is inevitable when running a clinical trial. Things may not always go the way you plan and that’s okay - it’s about adapting.

Issues with speed and quality of study activities arise when there is poor fragmentation across systems and study teams. Working with a CRO that has the tech capacity to quickly share data and implement changes as well as personnel who can act fast is absolutely crucial to avoiding delays in study milestones when the unexpected happens.

Watch the full episode of our fireside chat with Signos here: https://lnkd.in/dTCQb3XA

#clinicaltrials #cro #healthtech

Last week we announced the addition of Robert Langer to the Lindus Health advisory board, and we couldn’t be more excited about this exciting collaboration. Dr. Langer and our very own co-founder, Meri Beckwith, sat down with Drug Discovery & Development for a Q&A session to dive deeper into this new partnership - looking at Dr. Langer’s role and guidance for the future of Lindus Health.

Meri said: “Together, Lindus Health and Robert will continue innovating in how clinical trials can be best designed to both meet stringent regulatory requirements, while also focusing on getting new treatments into the hands of patients faster.”

Read the full article here: https://lnkd.in/eRpqkypM

#clinialtrials #biotech #healthtech

Lindus Health is honored to welcome Robert Langer, co-founder of Moderna and distinguished professor, to our advisory board!

Dr. Langer has more than 1,400 patents issued and pending globally to 400+ companies in pharmaceuticals, chemicals, biotechnology, and medical devices. As a biotech pioneer of our time, his expertise will be instrumental in furthering our mission to bring innovative therapies to market and improve patient outcomes.

Read the full press release here: https://lnkd.in/ePa4rwiV

#healthcareinnovation #clinicaltrials #advisoryboard

What does it mean to be nimble and tech-forward in clinical operations?

In our latest fireside chat with Signos Chief of Staff, Dan Gusz, we talk about just that as well as the challenges sponsors face time and time again when working with CROs as a result of fragmentation and asynchronous technologies.

Tune in to the full conversation here: https://lnkd.in/eQxeXRUd

Digital therapeutics have demonstrated great success in managing a broad range of chronic conditions, and it's crucial that these interventions receive insurance coverage like traditional pharmaceuticals. This is a great article highlighting strategies #DTx companies are employing to provide greater access to these innovative therapies.

#digitaltherapeutics #reimbursement #healthtech

As healthcare undergoes continual evolution, sponsors are expanding their scope beyond traditional biologics in efforts to develop innovative medical treatments. In our latest blog, we highlight how #digitaltherapeutics technologies like Cognito Therapeutics, Inc., Big Health, Mahana and more are changing the way millions of people receive treatment for various chronic conditions, sometimes even replacing the need for pharmaceutical medications.

Read on here: https://lnkd.in/eajdfWtp

#DTx #chronicconditions #healthtech

The J.P. Morgan Healthcare Conference stands out as the largest symposium for healthcare investment, serving as a pivotal platform to join emerging and innovative biotechnology companies, industry leaders, and investors. In this article by Drug Discovery & Development our co-founder Meri Beckwith shares his thoughts on how this year’s event highlighted the strategic plays biotech companies should prioritize looking ahead.

Read the full article here: https://lnkd.in/eUVKFbcC

ViVE Caribou Biosciences Eligo Bioscience SteadyMD Fauna Bio MPM BioImpact

#biotechnology #clinicaltrials #healthtech

Join us on February 21 to learn more about our advice on running #DTx studies in the EU!

#digitaltherapeutics #clinicaltrials #healthtech

#ThrowbackThursday to to CNS Summit 2023, where our Machine Learning Engineer, Ece Kavalci, presented a live demo of our internal, AI-based protocol generation tool 🧠👩🏻💻 

#machinelearning #LLMs #clinicaltrials

COM:LINDUSHEALTH

Lindus Health

locale

market

industry

website

crunchbase

linkedin

founding date

peer of

investor of

competitor of

Metrics